NCT01332279 2023-04-04
Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy
Fox Chase Cancer Center
Phase 1 Withdrawn
Clinical Trials
6 trialsNCT00900081 2017-08-01
Cyclooxygenase-2 Expression in Tissue Samples From Patients With a Normal Cervix, Cervical Intraepithelial Neoplasia, or Early Invasive Cervical Cancer
Wake Forest University Health Sciences
Withdrawn
NCT00898573 2015-10-02
Lapatinib Resistance in Patients With Breast Cancer
Case Comprehensive Cancer Center
Withdrawn
NCT00908739 2015-09-30
Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer
Case Comprehensive Cancer Center
Withdrawn
NCT00960427 2013-04-16
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery
Barbara Ann Karmanos Cancer Institute
Phase 1 Withdrawn
NCT00899002 2013-04-10
Biomarkers in Stored Tumor Samples From Younger Patients With Liver Cancer
Vanderbilt-Ingram Cancer Center
Withdrawn